Menu
Not yet recruiting NCT07701746

Ultrasound Guidance vs Landmark Technique for Internal Jugular Vein Catheterization

Observational Central Vein Catheter Ultrasound

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Ultrasound Guidance, Landmark Technique.
Who it may be relevant to
Registry conditions: Central Vein Catheter, Ultrasound. Basic parameters: 18 years — 75 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Effect of Ultrasound Guidance Versus Landmark Technique on the Number of Needle Redirections in Internal Jugular Vein Catheterization

Overview

Central venous catheterization (CVC) is a fundamental procedure in anesthesiology and reanimation practice for critical clinical processes such as hemodynamic monitoring, vasoactive drug infusion, and fluid resuscitation. The internal jugular vein (IJV) is frequently preferred due to its superficial anatomical location and ease of access. This study aims to observe and compare the ultrasound (USG) guidance and the landmark method in patients scheduled for IJV catheterization.

Detailed description

Traditionally, IJV catheterization applied with a blind technique based on anatomical landmarks is increasingly being replaced by USG-guided applications. However, the landmark method is still actively and widely used in the field due to equipment limitations or practical habits. A total of 144 patients aged 18-75 who are operated on in the general operating room unit and have a central venous catheter inserted will be included in this prospective study. Patients will be divided into two groups: those receiving USG-guided catheterization (n=72) and those receiving the landmark technique (n=72). All patients will receive standard general anesthesia after an 8-hour fasting period. The physician performing the cannulation with USG will have at least 2 years of USG experience and/or a certificate.

Interventions

  • Procedure Ultrasound Guidance
    Patients (n=72) receiving internal jugular vein catheterization performed with ultrasound guidance by an anesthesiologist with at least 2 years of USG experience or certification.
  • Procedure Landmark Technique
    Patients receiving internal jugular vein catheterization performed using the traditional blind/anatomical landmark technique (typically by residents or clinicians gaining experience).

Primary outcome measures

  • Number of Needle Redirections. [Time frame: Intraoperative.]
Secondary outcome measures (2)
  • First-Attempt Success Rate [Time frame: Intraoperative]
  • Total Access Time [Time frame: Intraoperative, up to 15 minutes]

Eligibility criteria

Inclusion criteria

  • Patients aged 18-75 years
  • Patients operated on in the general operating room unit
  • Patients undergoing central venous catheter insertion

Exclusion criteria

  • Refusal to participate in the study
  • Patients aged under 18 or over 75 years
  • Patients undergoing emergency surgery
  • Presence of coagulopathy
  • History of infection, operation, or cannulation in the intervention area
  • Allergy to USG gel

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Case-control

Study locations

Turkey (Türkiye) · 1 center
  • Dicle University — Diyarbakır

Publications

  • Sazdov D, Srceva MJ, Todorova ZN. Comparative Analysis of Ultrasound Guided Central Venous Catheterization Compared to Blind Catheterization. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2017 Sep 1;38(2):107-114. doi: 10.1515/prilozi-2017-0028. PMID 28991766

Identifiers

NCT: NCT07701746 · 320/2026

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗